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7-Methyltryptophan (7MT) or compounds which can be metabolized to 7MT,
3-methylanthranilic acid (3MA) and 7-methylindole, cause derepression of the
trp operon through feedback inhibition of anthranilate synthetase. Tyrosine re-
verses 3MA or 7-methylindole derepression, apparently by increasing the amount
of chorismic acid available to the tryptophan pathway. A mutant isolated on the
basis of 3MA resistance (MAR 13) was found to excrete small amounts of chorismic
acid and to have a feedback-resistant phenylalanine 3-deoxy-D-arabinoheptulosonic
acid-7-phosphate (DAHP) synthetase. Genetic evidence indicates that the muta-
tion conferring 3MA resistance and feedback resistance is very closely linked to
aroG, the structural gene for the DAHP synthetase (phe). Since feedback inhibition
of anthranilate synthetase by L-tryptophan (or 7MT) is competitive with chorismic
acid, alterations in growth conditions (added tyrosine) or in a mutant (MAR 13)
which increase the amount of chorismic acid available to the tryptophan pathway
result in resistance to 7MT derepression. Owing to this competitive nature of tryp-
tophan feedback inhibition of anthranilate synthetase by chorismic acid, the early
pathway apparently serves to exert a regulatory influence on tryptophan biosynthesis.
In Escherichia coli, the level of intermediates
in aromatic biosynthesis is regulated by several
different allosteric interactions. The end products
of the pathway (principally phenylalanine, tyro-
sine, and tryptophan) inhibit three isoenzymatic
forms of the first enzyme of the pathway, 3-deoxy-
D-arabinoheptulosonic acid-7-phosphate (DAHP)
synthetase, and further interact at the branch
point with the enzymes metabolizing chorismic
acid along the various specific biosynthetic routes
(1, 5, 6, 9, 15, 19, 20). Thus, alterations in the
levels of the allosteric effectors and the activities
of the allosteric enzymes would be expected to
demonstrate the complex regulatory inter-rela-
tionships in the aromatic pathway.
In the preceding paper (11), evidence was pre-
sented showing that compounds capable of being
metabolized to 7-methyltryptophan (7MT), i.e.,
3-methylanthranilic acid (3MA) and 7-methylin-
dole, inhibit growth and cause derepression of
the trp operon in wild-type strains of E. coli. Pre-
sumably, both phenomena are manifestations of a
tryptophan limitation caused by 7MT inhibition
I Taken in part from a thesis submitted to Marquette University
by W.A.H. in partial fulfillment of the requirements for the Ph.D.
degree.
of anthranilate synthetase. Unlike other methyl-
tryptophan analogues, 7MT does not appear to
function as an active corepressor.
In this report, we present evidence that ana-
logue-induced derepression is antagonized by the
inclusion of tyrosine in the growth medium of
wild-type cells, and that mutants with a feedback-
resistant DAHP synthetase (phe) are also re-
factory to this derepression. The most likely
explanation for these observations is that both
alterations increase the amount of chorismic acid
available to the tryptophan pathway, thereby
reversing the inhibitory effect of 7MT on anthran-
ilate synthetase. Thus, the early pathway involv-
ing the production of chorismic acid apparently
serves to exert a regulatory influence on trypto-
phan biosynthesis.
MATERIALS AND METHODS
Organisms. All mutants described were derived
from W1485 tna (a mutant lacking tryptophanase
isolated in this laboratory) except aroG (a mutant
lacking the phenylalanine-inhibitable DAHP synthe-
tase), obtained from K. D. Brown. The parent strain
of aroG is W1485. The mutants were obtained by
ultraviolet or nitrosoquanidine treatment and plating
on appropriate selective media. 3MA-resistant
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mutants were obtained by plating mutagen-treated
cells on minimal agar plates containing 6.7 X 10-4 M
3MA.
Transduction procedures. Plkc transducing lysates
of the mutants were prepared by the confluent lysis
technique (13). Control lysates from wild-type strains
and controls for sterility were done routinely.
Growth media. All strains and mutants were grown
in the minimal medium of Vogel and Bonner (18)
containing 0.5% glucose and other supplements as
desired. The cultures were agitated on a rotary shaker
at 37C. Growth curves were obtained by growing
50-ml cultures in a 500-ml side-arm flask and esti-
mating growth at various times by turbidity at 660 nm.
Chemicals. D-Erythrose-4-phosphate dimethylacetal
dicyclohexylammonium salt was obtained from Calbio-
chem, Los Angeles, Calif., and converted to free
erythrose-4-phosphate by the method of Ballou,
Fischer, and MacDonald (2) before use. Chorismic
acid was prepared as the free acid according to the
procedure of Gibson (10). All other chemicals were
obtained commercially.
Preparation of extracts. Cells were harvested by
centrifugation, washed once in saline, and resuspended
in 0.1 M K2HPO4, pH 7.0, containing 10-3 M 2-mer-
captoethanol and 10-3 M ethylenediaminetetraacetate
(EDTA). The cells were broken by sonic oscillation,
and cell debris was removed by centrifugation at
30,000 X g for 30 min. For assay of DAHP synthe-
tase, extracts were prepared in 5 X 10-2 M K2HPO4,
pH 7.0, containing 10-3 M 2-mercaptoethanol.
Enzyme assays. The a subunit of tryptophan
synthetase (A protein) was assayed according to
Smith and Yanofsky (16), and anthranilate synthetase
was assayed as described in the preceding paper (11).
DAHP synthetase was assayed according to the
procedure of Doy and Brown (7), except that the
reaction mixture contained 10-3 M Co2+ (see below).
After heating with thiobarbituric acid, the reaction
tubes were cooled briefly and extracted with 4.0 ml
of cyclohexanone to avoid the turbidity usually en-
countered in the assay. The concentration of DAHP
in the cyclohexanone was determined spectrophoto-
metrically at 549 nm by use of a molar extinction
coefficient of 6.0 X 104.
A unit of enzyme activity is equivalent to 1 ,umole
of substrate consumed or product formed per minute
at 37 C. Specific activity is given as units per milligram
of protein. The protein was determined by the method
of Lowry et al. (14). In some cases (relative activity),
the specific activity relative to that found in W1485
tna grown in minimal medium was used. A relative
activity of 1.0 corresponds to 0.0027 units of anthranil-
ate synthetase per mg of protein and 0.0152 units of
tryptophan synthetase A protein per mg of protein.
Co+2 activation of DAHP synthetase. A recent
report indicated that the DAHP synthetase (trp) is
stimulated by Co+2 (15). We have found that Co+2
appears to activate DAHP synthetase in crude extracts
or partially purified preparations of W1485 tna which
contain predominantly the DAHP synthetase (phe).
Table 1 shows the effect of various cations on the total
DAHP synthetase activity in crude extracts of W1485
tna which was dialyzed overnight in buffer containing
TABLE 1. Cation activation of DAHP synthetase
Cationa DAHP synthetaserelative activityb
None....100
Co+2 . 182
Mg+2.... 104
Mn+2 .. 158
Zn+2.... 65
Fe+2... 69
Fe+3... 41
EDTA... 16
a Cations were added to DAHP synthetase
reaction mixture at a concentration of 1I- M.
b A crude extract of W1485 tna dialyzed over-
night in buffer containing 10- M EDTA was used
as a source of enzyme.
10-3 M EDTA. It is apparent that Co+2 and Mn+2
significantly stimulate DAHP synthetase activity and
that EDTA almost completely inhibits the reaction.
Maximal activation of DAHP synthetase occurs at
10-' M Co+2, and this concentration was used in all
subsequent experiments.
Diethylaminoethyl (DEAE)-Sephadex chromatog-
raphy. DEAE-Sephadex chromatography was carried
out on a column of 2.5 X 32 cm by use of a linear
gradient elution starting with 350 ml of 10-2 M K2-
HPO4, pH 7.0, plus 0.1 M KCI in the mixing bottle
and 350 ml of 10-2 M K2HPO4, pH 7.0, plus 0.6 M
KCL in the inlet bottle. Eluting buffers contained
10-' M 2-mercaptoethanol. Nucleic acids were not
removed before crude extracts were placed on the
column. At the end of the fractionation, a small
amount of 10-2 M K2HPO4, pH 7.0, containing 1.0 M
KCl was washed through the column to insure that
all DAHP synthetase activity had been eluted. Re-
covery of DAHP synthetase varied between 32 and
58%.
RESULTS
Since the analogue-induced trp operon dere-
pression results from tryptophan limitation, it
should be reversed by added tryptophan or pre-
cursors such as anthranilic acid and indole. Table
2 shows that these compounds did repress cul-
tures exposed to the analogues and that an early
intermediate, shikimic acid, had only a slight
effect in decreasing the enzyme levels. Shikimate
is a precursor of chorismic acid and, in light of
the arguments presented below, we have no
ready explanation for its relative ineffectiveness.
Table 2 further shows that tyrosine, but not
phenylalanine or a mixture of the two, effectively
reversed the derepression. We felt that, as inhibi-
tion of anthranilate synthetase by tryptophan
(or 7-methyltryptophan) is competitive with
chorismic acid (1, 11), tyrosine reversal of 3MA
and 7-methylindole derepression might be due to
tyrosine causing increased chorismic acid avail-
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TABLE 2. Effect of aromatic amino acids and some
precursors on 3-methylanthranilic acid and
7-methylindole derepression ofanthranilate
synthetase in W1485 tna
Growth conditions Additions mnnlResactivitye/ml) atvt
Minimal medium None 1.0
Phenylalanine .30 1.4
Tyrosine .28 0.68
Tyrosine + .28
phenylalanine .30 2.0
Minimal medium None - 17.0
+ 0.2,umole of L-Tryptophan .05 1.8
3-methylanthra- Indole .068 2.5
nilic acid/ml Anthranilic acid .058 2.6
Shikimic acid .29 12.8
Phenylalanine .30 11.0
Tyrosine .055 8.1
Tyrosine .28 0.96
Tyrosine + .28
phenylalanine .30 13.4
Minimal medium None - 17.3
+ 0.1 ,umole of Tyrosine .28 4.9
7-methylindole/ Tyrosine + .28
ml phenylalanine .30 12.9
able to the tryptophan pathway. To test this pos-
sibility, a tryptophan auxotroph, trpD2, was
grown overnight on limiting tryptophan supple-
mented with tyrosine alone, or tyrosine and
phenylalanine; the cells were washed and then
incubated with several mixtures of the aromatic
amino acids. As trpD2 accumulates anthranilic
acid under the growth conditions used in the
experiment and is derepressed for anthranilate
synthetase, the rate of anthranilic acid accumula-
tion is a measure of the amount of chorismic acid
available for tryptophan biosynthesis. Table 3
indicates that trpD2 accumulated more anthra-
nilic acid in the presence of tyrosine than in
minimal media, and much more than when both
phenylalanine and tyrosine were present. Under
these different conditions, anthranilate synthetase
was derepressed to approximately the same de-
gree. The results support the hypothesis that
tyrosine reversal of 3MA or 7-methylindole dere-
pression is due to its influence on the amount of
chorismic acid available to the tryptophan path-
way.
Some mutants isolated on the basis of 3MA
resistance did not derepress on medium con-
taining 3MA or 7-methylindole (Table 4) and
are unlinked by transduction to the tryptophan
operon (11). Preliminary studies of 3MA re-
sistance in one of these mutants, MAR 13, indi-
cated that the mutant accumulated small amounts
of chorismic acid. From Table 5 it is apparent
that a compound accumulated in MAR 13 super-
natant fluid (but not in W1485 tna or trp E2FBR2-
50) which could be converted to anthranilic acid
with highly purified anthranilate synthetase.
Formation of anthranilic acid from the compound
which accumulated in MAR 13 supernatant fluid
required the complete anthranilate synthetase
reaction mixture, including both glutamine and
MgC92. This compound is probably chorismic
acid. Thus, it appeared that the mutational
alteration conferring 3MA resistance in MAR 13
might affect regulation of the early pathway of
aromatic biosynthesis.
DAHP synthetase is the first enzyme specific
TABLE 3. Anthranilic acid accumulation by trpD2
in the presence of aromatic amino acidsa
Anth- Amt of anthranilic
Accumu ranilate acid/109 cellsGrowth lation -synthe- (unoles/ml)
conditions conditions (ntase
mg) 1 hr 2 hr 3 hr
Trp None .103 .118 .226 .303
Trp + tyr Tyr .086 .135 .264 .382
Trp + tyr + Tyr + .088 .031 .057 .086
phe phe
a The concentrations of amino acids in the
growth or accumulation media (in 10-2 ,moles/ml)
were as follows: tryptophan (trp), 2.5; tyrosine
(tyr), 28; phenylalanine (phe), 30.
b The concentration of anthranilic acid was
determined by acidifying 1.0 ml of supernatant
fluid from the accumulation media with 0.1 ml of
1 N HCI and extracting with ethyl acetate. The
concentration of anthranilic acid in the ethyl
acetate layer was determined spectrophoto-
metrically at an absorption maximum of 336 nm.
TABLE 4. Resistance to 3-methylanthranilic acid
(3MA) and 7-methylindole (7MIn) derepression
of anthranilate synthetase and A protein in
MAR 13
Relative specific activity
Strain Anthranilate synthetase A protein
Mini- Mini-
mal 3MAa 7MIna mal 3MA 7MIn
medium medium
W1485.... 1.0 19.4 20.1 1.0 11.8
MAR 13.. 0.37 0.87 2.3 0.42 0.72 2.2
a Strains were grown in minimal medium, or
minimal medium containing 0.2 ,umole of 3MA/ml
or 0.2 ,mole of 7MIn/ml.
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for aromatic amino acid biosynthesis (17). Previ-
ous reports have indicated that there are three
isoenzymatic DAHP synthetases in E. coli (6, 15,
19, 20), one inhibited by phenylalanine, one by
tyrosine, and one by tryptophan. Since DAHP
synthetase plays an important role in the overall
regulation of aromatic biosynthesis, a mutation
giving rise to increased chorismic acid production,
such as in MAR 13, might be due to an altera-
tion in the amount or properties of DAHP syn-
thetase. As shown in Table 6, the DAHP synthe-
tase activity in MAR 13 was only slightly inhibited
by phenylalanine, whereas in W1485 tna more
than 80% of the total DAHP synthetase was
inhibited by phenylalanine. The total amount of
DAHP synthetase activity in crude extracts of
MAR 13 was similar to that found in wild-type
W1485 tna. A mutant which entirely lacks the
phenylalanine-inhibitable DAHP synthetase ac-
tivity, aroG (19), had only about 10% of the total
activity found in wild-type strains. Unlike MAR
13, the DAHP synthetase activity not inhibited
by phenylalanine in aroG was inhibited by tyro-
sine and tryptophan. Therefore, it appeared that
MAR 13 has an altered phenylalanine DAHP
synthetase which renders it resistant to feedback
inhibition by phenylalanine.
To determine whether the mutation to 3MA
resistance was due to an altered phenylalanine
TABLE 5. Detection of a compound in MAR 13
culture supernatant which can be converted to
anthranilic acid by purified
anthranilate synthetasea
Anthranilic
acid formed/
Culture supernatant fluidb Amt tested ml of
supernantant
fluid
ml pmoles
W1485 tna .................. .4 .0003
trpEFBR2S50................. .4 .0003
MAR 13
....................
2 .0120
MAR 13.................... .4 .0108
MAR 13 (ether extract)c. .3400
a An excess of purified anthranilate synthetase-
PR transferase complex (specific activity = 2.25
units/mg) was added, and the reaction was al-
lowed to continue until no further anthranilic acid
was formed.
bCulture supernatant fluids were tested for
presence of "chorismic acid" by use of the stand-
ard anthranilate synthetase reaction mixture
minus chorismic acid.
c MAR 13 ether extract was obtained by extract-
ing 500 ml of MAR 13 culture supernatant under
acid conditions with ethyl ether, and evaporating
(in vacuo) over 5.0 ml of 0.1 M K2HPO4, pH 7.0,
until all ether was removed.
TABLE 6. DAHP synthetase activities and
inhibition by aromatic amino acids
Inhibition (%)b
Straina Specificactivity Phenyl- Tyrosine, T9rpto-
alanine, 10-a phan,10-a ,m 10-a m
W1485 tna.. .0962 83.2 21.6 19.8
MAR 13... .0978 4.6 3.9 12.6
aroG.. .0067 13.5 63.5 73.0
a Each of the strains was grown in minimal
medium containing 0.5% glucose.
b The sum of the amount of inhibition by each
of the aromatic amino acids may be more than
100% owing to some cross-inhibition.
DAHP synthetase, MAR 13 was transduced into
aroG. More than 90% of the wild-type recom-
binants from this cross did not derepress on
3MA (Table 7), indicating that the 3MA-resist-
ant locus in MAR 13 is very closely linked to
aroG. Table 8 shows that, in addition to not dere-
pressing on 3MA, these recombinants also have
acquired the feedback-resistant DAHP synthe-
tase. Isolates from a control cross between wild-
type W1485 tna and aroG are shown for compari-
son.
Crude extracts of W1485 tna, MAR 13, and
aroG (Fig. 1) were chromatographed on DEAE-
Sephadex to determine whether the relative
proportions of the various isoenzymes had been
altered in MAR 13. Although resolution of the
isoenzymes was not attained, there were indica-
tions of differences in the three strains. Wild-type
W1485 tna (Fig. 1) had one definite peak preceded
by a very broad region which may be heterogene-
ous in composition. It is apparent that all frac-
tions contained phenylalanine-inhibitable DAHP
synthetase activity, although the major peak con-
tained the most. MAR 13, however, had one
main peak of DAHP synthetase activity, not
inhibitable by phenylalanine. This peak was
preceded by a small shoulder and may correspond
to that seen in W1485 tna, although it appears to
be considerably reduced in MAR 13. Apparently
the tryptophan- and tyrosine-inhibitable DAHP
synthetases are not present in high enough con-
centrations in MAR 13 to be detected after chro-
matography, as those activities would likely be
repressed in this strain (Table 6). Strain aroG (Fig.
1) showed a single narrow peak which was in-
hibited by tryptophan. Although 60% of the ac-
tivity of aroG in crude extracts was inhibited by
tyrosine, very little tyrosine-inhibitable DAHP
synthetase activity was detected after chromatog-
raphy. The reason for this is unknown.
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TABLE 7. Recombination between MAR 13
and aro G
No. of
wild-typea No. dere-
Donor Recipient recom- pressedA
binants on 3MAO
tested
W1485 tna........ aro G 23 23
MAR 13 ........... aroG 37 3
a Selection of "wild-type" recombinants was
for growth in the presence of tyrosine and trypto-
phan, as aro G does not grow in the presence of
these two amino acids (19).
b The recombinants were purified by single-
colony isolation and grown in the presence of 0.2
,mole of 3MA/ml. The whole-cell assay for trypto-
phan synthetase (12) was used to determine
whether 3MA had caused derepression.
TABLE 8. DAHP synthetase and A protein activites
in recombinants between MAR 13 and aroG
Specific activity Inhibi-
Growth tion by
Recombinant condi- DAHP phelnyl-ticnsa AH alanineA protein syn- (%)b
thetase
W1485 tna X aro G
No. 1 3MA .1057 .0780 83.7
No. 2 3MA .1222 .0805 85.4
No. 19 Min .1132 91.7
No. 21 Min .1119 92.6
MAR 13 X aro G
No. 1 3MA .0063 .0650 9.6
No. 2 3MA .0045 .0613 10.4
No. 29 Min .0902 8.2
No. 30 Min .0648 5.0
No. 31 Min .0877 3.6
No. 32 Min .0733 5.9
a Recombinants from crosses shown were grown
overnight in minimal medium (Min) or minimal
medium containing 0.2 smoles of 3MA/ml (3MA).
b The column indicates the per cent inhibition
of DAHP synthetase by 10- M phenylalanine.
DISCUSSION
The early pathway of aromatic biosynthesis
exerts a regulatory influence on tryptophan pro-
duction, because tryptophan feedback inhibition
of anthranilate synthetase is competitive with
chorismic acid. Thus, repression of the tryptophan
operon in the presence of the derepressing ana-
logue 7MT (or 3MA and 7-methylindole which
are metabolized to 7MT) is a sensitive indicator
of the amount of chorismic acid available to the
tryptophan pathway.
Tyrosine at high concentrations can fully
reverse 3MA derepression. Previous reports indi-
cate that tyrosine stimulates the synthesis of the
phenylalanine-inhibitable DAHP synthetase (4),
the dominant DAHP isoenzyme in E. coli. Tyro-
sine would be expected to repress enzymes of the
tyrosine pathway as well as inhibit prephenate
dehydrogenase. This would make more chorismic
acid available for other pathways (i.e., the tryp-
tophan pathway). This hypothesis is supported
by the experiments which demonstrate that trpD2
accumulates more anthranilic acid in the presence
of tyrosine than in minimal medium. Also, if
tyrosine increases the amount of chorismic acid
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FIG. 1. DEAE-Sephadex chromatography of crude
extracts of wild-type W1485 tna, MAR 13, and aroG.
Solid circles indicate DAHP synthetase activity; open
circles, protein. Bar graph indicates the per cent inhi-
bition by phenylalanine (solid bar), tyrosine (striped
bar), or tryptophan (open bar). Only those fractions
containing DAHP synthetase activity are shown. A
total of120 fractions ofabout 6 ml each were collected.
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available to the tryptophan pathway, tyrosine
should indirectly reverse the normal tryptophan
feedback inhibition of anthranilate synthetase,
causing increased tryptophan synthesis and re-
pression. Thus, wild-type cells grown on tyrosine
alone are slightly repressed (Table 2).
Tyrosine and phenylalanine together are inef-
fective in reversing 3MA or 7-methylindole
derepression. Also, W1485 tna grown in minimal
medium supplemented with phenylalanine and
tyrosine is slightly derepressed (Table 2). This
has been noted by other investigators (3), and
has been attributed to an inhibition of the phen-
ylalanine and tyrosine isoenzymatic DAHP syn-
thetases. Presumably, the amount of DAHP
formed by the tryptophan DAHP synthetase is
insufficient to allow production of tryptophan
at repressing levels. This conclusion is also sup-
ported by experiments which show that trpD2
accumulates much less anthranilic acid in the
presence of phenylalanine and tyrosine than in
minimal media with or without tyrosine. Thus,
tyrosine and phenylalanine together do not re-
verse 3MA derepression because less chorismic
acid is available for the tryptophan pathway.
Since tyrosine reversal of 3MA derepression
appears to be related to increased amounts of
chorismic acid, it should be possible to reverse
3MA derepression by supplying chorismic acid
in the growth medium. However, chorismic acid'
cannot be utilized for growth of aromatic auxo-
trophs blocked prior to chorismic acid synthesis
(9). Apparently, chorismic acid does not enter
cells in sufficient quantities to allow growth of
auxotrophs, and thus it was not possible to test
the effects of chorismic acid on 3MA derepres-
sion directly. Shikimic acid, which can be utilized
for growth by aromatic auxotrophs and can be
converted to chorismic acid, however, does not
reverse 3MA derepression. A possible explana-
tion for this observation is that the chorismic
acid formed from shikimic acid would be expected
to be utilized for both tyrosine and phenylalanine
biosynthesis as well as tryptophan biosynthesis.
The concentration of shikimate used (or the
rate at which it is metabolized) may not be high
enough to raise the phenylalanine and tyrosine
concentrations to levels which would cause repres-
sion of the phenylalanine and tyrosine pathways
or significantly feedback-inhibit these pathways.
Although tyrosine would inhibit DAHP syn-
thetase (tyr), this probably does not significantly
decrease chorismic acid synthesis. But the tyro-
sine pathway would be repressed and prephenate
dehydrogenase would be markedly inhibited,
resulting in an increase in the level of chorismate
for the tryptophan pathway.
MAR 13, a mutant which is resistant to 3MA
derepression, provides further evidence that al-
terations in the early pathway may affect trypto-
phan biosynthesis. This mutant appears to excrete
small amounts of chorismic acid. Genetic analy-
sis has shown that the locus which confers 3MA
resistance is closely linked to aroG, the structural
gene for the phenylalanine-inhibitable DAHP
synthetase (19). The basis of 3MA resistance in
this mutant appears to be an altered DAHP syn-
thetase which is not subject to feedback inhibi-
tion by phenylalanine.
The DAHP synthetase (phe) is the predominant
enzyme in E. coli, and in MAR 13 this enzyme is
feedback-resistant, resulting in a relatively large
increase in the level of chorismate formed. This
may result in increased levels of phenylalanine
and tyrosine, which would repress and inhibit
their respective pathways but would not signifi-
cantly inhibit chorismate formation. The result
is an excess of chorismic acid available for the
tryptophan pathway which reverses 7MT in-
duced derepression.
Ezekiel (8) has described a mutant similar to
MAR 13 in E. coli B Luria. This mutant, selected
for resistance to thienylalanine, had a normal
amount of DAHP synthetase but, unlike MAR
13, about half the enzyme in crude extracts was
inhibited by tyrosine, and the other half was
insensitive to inhibition by phenylalanine. Al-
though crude extracts of MAR 13 contain very
low tryptophan- and tyrosine-inhibitable DAHP
synthetase activity, there appeared to be a pos-
sibility that the mutation in MAR 13 resulted in
a complete loss of DAHP synthetase (phe) and a
concomitant increase in the amount of the other
isoenzymes. Therefore, crude extracts of MAR 13
were chromatographed on DEAE-Sephadex.
Previous reports (19, 20) have indicated that the
DAHP synthetase isoenzymes could be separated
by DEAE cellulose chromatography. Preliminary
experiments in this laboratory with DEAE cellu-
lose chromatography resulted in poor recoveries,
so DEAE-Sephadex, which gave better recoveries
and might be expected to give better separation,
was used. However, separation of the DAHP
isoenzymes by DEAE-Sephadex chromatography
into definite peaks was not obtained. This may
be due to the relatively low levels of the tyrosine
and tryptophan isoenzymes present in crude
extracts, or possibly to other factors. However,
it is evident that the major peak of enzyme ac-
tivity in W1485 tna is inhibited by phenylalanine,
whereas in MAR 13 this peak is not inhibited by
phenylalanine or by tyrosine and tryptophan.
Thus, it is unlikely that the mutation in MAR 13
results in increased amounts of the tyrosine or
tryptophan DAHP synthetase; rather, it probably
is due to an altered phenylalanine DAHP syn-
207VOL. 101, 1970
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thetase which is not feedback-inhibited by phen-
ylalanine. This conclusion is also supported by
genetic evidence which indicates that the muta-
tion conferring 3MA resistance and feedback
resistance to the DAHP synthetase (phe) is
closely linked to aroG.
Growth of wild-type cells in the presence of
tyrosine or mutations to a feedback-resistant
DAHP synthetase (phe) appear to increase the
amount of chorismic acid available for trypto-
phan biosynthesis which alters the regulatory
properties of the tryptophan operon. Thus, the
competitive nature of tryptophan feedback inhibi-
tion of anthranilate synthetase by chorismic acid
appears to be an important regulatory function
which allows for increased tryptophan biosyn-
thesis under conditions where more of the early
intermediates are being produced.
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